FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Backing a Brexit-like Referendum

Nigel Farage, one of the main promoters of the Brexit campaign,…
FDA Authorizes Novavax COVID Vaccine

China on Track for 1,000 Warheads by 2030

The Chinese military is rapidly building up its strategic…
FDA Authorizes Novavax COVID Vaccine

China Sparks Prepper Frenzy

The Chinese Ministry of Commerce issued a notice for families…